(Q34614695)

English

Mild hemophilia A.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

Mild hemophilia A. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

0 references

author name string

M Franchini

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

E J Favaloro

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

G Lippi

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

7 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

421-432

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

The hemophilias--from royal genes to gene therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Haemophilia care in China: achievements of a decade of World Federation of Hemophilia treatment centre twinning activities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Practice patterns in haemophilia A therapy -- global progress towards optimal care

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

The Canadian Hemophilia Registry as the basis for a national system for monitoring the use of factor concentrates.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

A web-based registry of inherited bleeding disorders in the region of Emilia-Romagna: results at three and a half years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

What factors influence the age at diagnosis of hemophilia? Results of the French hemophilia cohort

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Superficial fibromatosis mimicking subcutaneous hematoma: an unusual and difficult diagnosis in a patient with mild hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Bleeding in carriers of hemophilia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Diagnosis of factor VIII deficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Emerging technologies and quality assurance: the United Kingdom National External Quality Assessment Scheme perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Age-dependent increase of FVIII:C in mild haemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Mild hemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Molecular mechanisms of mild and moderate hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Mild/moderate haemophilia A: new insights into molecular mechanisms and inhibitor development.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

The molecular basis of hemophilia A: genotype-phenotype relationships and inhibitor development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Characterization of mutations within the factor VIII gene of 73 unrelated mild and moderate haemophiliacs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Four hydrophobic amino acids of the factor VIII C2 domain are constituents of both the membrane-binding and von Willebrand factor-binding motifs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372----histidine).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

A Tyr346-->Cys substitution in the interdomain acidic region a1 of factor VIII in an individual with factor VIII:C assay discrepancy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Mutating factor VIII: lessons from structure to function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Diagnostic importance of the two-stage factor VIII:C assay demonstrated by a case of mild haemophilia associated with His1954-->Leu substitution in the factor VIII A3 domain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish family

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay results

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Mutations in a subgroup of patients with mild haemophilia A and a familial discrepancy between the one-stage and two-stage factor VIII:C methods

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Inhibitor development in one patient and laboratory discrepancies in several families with both mild haemophilia and Arg531Cys mutation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Molecular mechanisms underlying hemophilia A phenotype in seven females

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Molecular genetic testing of hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Identification and prevalence of von Willebrand disease type 2N (Normandy) in Australia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Recent acquisitions in acquired and congenital von Willebrand disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Laboratory identification of von Willebrand disease: technical and scientific perspectives

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

The role of molecular genetics in diagnosing von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Survival in a cohort of patients with haemophilia at the haemophilia care center in Vienna, Austria, from 1983 to 2006.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Life expectancy in hemophilia outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Factors predictive of death among HIV-uninfected persons with haemophilia and other congenital coagulation disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Mortality in patients with hemophilia. Changes in a Dutch population from 1986 to 1992 and 1973 to 1986.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Mortality before and after HIV infection in the complete UK population of haemophiliacs. UK Haemophilia Centre Directors' Organisation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

The impact of HIV on mortality rates in the complete UK haemophilia population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Epidemiology of hemophilia and of HIV infection in Italy. GICC. Gruppo Italiano Coagulopatie Congenite.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Causes of death in Canadians with haemophilia 1980-1995. Association of Hemophilia Clinic Directors of Canada

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Mortality and causes of death in Dutch haemophiliacs, 1973-86.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Challenges and controversies in haemophilia care in adulthood

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Cardiovascular disease in patients with hemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Co-morbidity in the ageing haemophilia patient: the down side of increased life expectancy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Hemophilia, cancer and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Decreased mortality of ischaemic heart disease among carriers of haemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Prevalence and risk factors for heart disease among males with hemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Health-related quality of life in a cohort of adult patients with mild hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Role of the intrinsic coagulation pathway in atherogenesis assessed in hemophilic apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Hemophilia A, von Willebrand disease, and atherosclerosis of abdominal aorta and leg arteries: factor VIII and von Willebrand factor defects appear to protect abdominal aorta and leg arteries from atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Does hemophilia protect against atherosclerosis? A case-control study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Endothelial dysfunction in haemophilia patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Myocardial infarction and other arterial occlusions in hemophilia a patients. A cardiological evaluation of all 42 cases reported in the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Cardiac surgery and catheterization in patients with haemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Are haemophiliacs protected against cancer development? Prospective controlled studies are needed

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Hemophilia and cancer: a new challenge for hemophilia centers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

The epidemiology of inhibitors in haemophilia A: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

The multifactorial etiology of inhibitor development in hemophilia: genetics and environment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Factor VIII inhibitors in mild and moderate-severity haemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Characteristics of inhibitors in mild/moderate haemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Factor VIII antibody in a patient with mild haemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

High responding factor VIII inhibitors in mild haemophilia - is there a link with recent changes in clinical practice?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Analysis of factor VIII mRNA reveals defects in everyone of 28 haemophilia A patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

The identification and classification of 41 novel mutations in the factor VIII gene (F8C).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Environmental and genetic factors influencing inhibitor development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Inhibitor development in patients with hemophilia A after continuous infusion of FVIII concentrates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Continuous infusion of coagulation factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Intensive peri-operative use of factor VIII and the Arg593-->Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

The use of desmopressin as a hemostatic agent: a concise review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

The use of haemostatic drugs in haemophilia: desmopressin and antifibrinolytic agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

DDAVP challenge tests in boys with mild/moderate haemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Hyponatremia and seizures in young children given DDAVP.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

DDAVP use during pregnancy: an analysis of its safety for mother and child

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Characterization of a novel mutation in the F8 promoter region associated with mild hemophilia A and resistance to DDAVP therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Mild and moderate factor VIII deficiency: inhibitor risks

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Can we prevent inhibitors in mild and moderate factor VIII-deficient patients?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Hemostatic drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

One-stage clotting versus chromogenic assays for assessing recombinant factor VIII: two faces of a haemostasis coin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Successful treatment of high titer inhibitors in mild hemophilia A with avoidance of factor VIII and immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Effective and safe use of recombinant factor VIIa (NovoSeven) in elderly mild haemophilia A patients with high-titre antibodies against factor VIII.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Factor VIII inhibitor in a patient with mild haemophilia A and an Asn618-->Ser mutation responsive to immune tolerance induction and cyclophosphamide.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Rituximab in the treatment of acquired factor VIII inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients' analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Genetic testing for von Willebrand disease: the case against

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03717.X

21 January 2018

Identifiers

10.1111/J.1538-7836.2009.03717.X

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34614695&oldid=1985137045"